Pathophysiological, epidemiological and genetic studies convincingly showed lipoprotein
(a)(Lp (a)) to be a causal mediator of atherosclerotic cardiovascular disease (ASCVD). This …

There is now significant evidence to support an independent causal role for lipoprotein
(a)(Lp (a)) as a risk factor for atherosclerotic cardiovascular disease. Plasma Lp (a) …

Lipoprotein (a)(Lp (a)) is a low-density lipoprotein (LDL) cholesterol-like particle bound to
apolipoprotein (a). Increased Lp (a) levels are an independent, heritable causal risk factor …

It has been estimated that∼ 37% of the US population judged to be at high risk for
developing coronary artery disease (CAD), based on the National Cholesterol Education …

Purpose To review current knowledge of elevated lipoprotein (a)[Lp (a)] levels in relation to
atherosclerotic cardiovascular disease (ASCVD) and discuss their potential use as …

The present article is aimed at outlining the current state of knowledge regarding the clinical
value of lipoprotein (a)(Lp (a)) as a marker of cardiovascular disease (CVD) risk by …

ABSTRACT Introduction: Lipoprotein (a)[Lp (a)] is a potent, highly heritable and common risk
factor for atherosclerotic cardiovascular disease (ASCVD). Evidence for a causal association …

PERSPECTIVES STRUCTURE OF LIPOPROTEIN (a) AND APOLIPOPROTEIN (a):
FUNCTIONAL IMPLICATIONS DETERMINATION OF PLASMA LP (A) LEVELS …

The aim of this review is to highlight the role of lipoprotein (a)[Lp (a)] in atherogenesis and
coronary artery disease. After 40 years from discovery, Lp (a) still remains an enigma and …

0022-2143/2002 $35.00+ 0 5/1/121769 doi: 10.1067/mlc. 2002.121769 ipoprotein (a), a
complex composed of APO ((a))(a plasminogen-like protein) and APOB on a lowdensity …